Occupational dermatitis (OCD) is a skin inflammatory disease caused by allergens and irritant agents in the workplace. The disease is related to hypersensitivity reaction, which is correlated with an immunological mechanism (allergic contact dermatitis) and a nonimmunological mechanism (irritant contact dermatitis). Patients with atopic history (rhinitis allergy, asthma, and atopic dermatitis) have a higher risk of contracting OCD. Atopic individuals suffer from barrier skin damage that increases the risk of allergen and irritant penetration. Inflammatory reaction involves T-helper 1 (Th1), which produces cytokine tumor necrosis factor alpha (TNF-α) and interferon-γ (INF-γ), while T-helper 2 (Th2) produces interleukin (IL-4, IL-6, IL-8, IL-10). Eicosapentaenoic acid (EPA) is an omega-3 substance from polyunsaturated free fatty acids (PUFAs) that has been shown to have an anti-inflammatory effect and the ability to decrease macrophage accumulation. In the inflammatory process, EPA inhibits IL-6, IL-8, and TNF-α, which are mediated by the free fatty acid-binding proteins (FABPs). The aim of this study was to determine the bioactivity compound of EPA for anti-inflammatory agents and its target, based on in silico screening. The bioinformatic tools based on reverse docking used in this study were the PubChem compound database, the protein target prediction database, PharmMapper, SwissTargetPrediction, molecular docking software PyRx 0.8, ligand docking, and binding site analysis using PyMOL
software. Docking and binding site analysis showed that EPA was able to interact with FABPs, with the binding affinity of EPA with FABP 4 higher (-4.2 kcal/mol) than that of hydrocortisone with FABP 4 (-7.4 kcal/mol). EPA has the same binding site and relative bonding power as the FABPs; thus, it has potential as an alternative anti-inflammatory medicine in OCD.
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Introduction
The National Institute of Occupational Safety and Health (NIOSH) has included dermatologic disorders among the top 10 work-related diseases and injuries in the United States. The most common injuries are caused by lacerations, punctures, abrasions, and burns. Occupational contact dermatitis (OCD) is a skin inflammatory disease caused by allergens and irritant agents at the workplace. The disease is related to hypersensitivity reaction, which is correlated with an immunological mechanism (allergic contact dermatitis) and a nonimmunological mechanism (irritant contact dermatitis) [1] . Contact dermatitis accounts for 90 percent of occupational skin diseases. Among host-related factors, atopic dermatitis has been the most investigated risk factor in the development of occupationally induced skin diseases, particularly adult atopic hand dermatitis. Individual atopic dermatitis has a reduced threshold for developing irritant contact dermatitis from soap, detergents, solvents, and chemical irritants [1, 2] .
Patients with atopic history (rhinitis allergy, asthma, and atopic dermatitis) have a higher risk of contracting OCD. Atopic individuals suffer from barrier skin damage that increases the risk of allergen and irritant penetration. The inflammatory reaction involves T-helper 1 (Th1), which produces tumor necrosis factor alpha (TNF-α) and interferon-γ (INF-γ), while T-helper 2 (Th2) produces interleukin (IL-4, IL-6, IL-8, IL-10). The worldwide prevalence of AD has increased in the past three decades. It often begins during early childhood, and adult patients frequently suffer from chronic diseases.The etiology of atopic dermatitis is unknown, but most individuals who are affected are diagnosed with allergic manifestations (e.g., asthma, food allergies, seasonal allergies), and there is no definitive treatment for AD [1] [2] [3] . disorders, mental health and psychiatric disorders, and cardiovascular disorders as well as immunologic and inflammatory responses [4] . EPA cannot be produced by human bodies; it is primarily found in dietary fish oils and can also be derived from plant products such as margarine [4, 5] . EPA has been shown to have anti-inflammatory effects, and its biological effects are mediated by the production of pre-resolving mediators, which have been proposed to modulate and likely resolve inflammatory responses [5, 6] . This study aims to discover the natural bioactivity compounds of eicosapentaenoic acid (EPA) derived from fish oils and margarine for the treatment of occupational contact dermatitis, based on in silico screening.
Methods

Ligand preparation
The 3D chemical structure and simplified molecular-input line-entry system (SMILES) of EPA were obtained from the PubChem compounds database (https://pubchem.ncbi.
nlm.nih.gov/) with ID number: CID 446284.
Target selection
The target protein for EPA was obtained by entering SMILES into multiple servers, 
Molecular docking
Molecular docking for EPA, the target proteins, and the compound control was performed using the PyRx 0.8 software.
Molecular visualization and intermolecular interaction
Interaction between EPA, the target proteins, and the control compounds was visualized and analyzed using PyMOL and LigPlus as well as the BIOVIA Discovery Studio 2016 Client.
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Results
The results of the target selection using PharmMapper ( job ID clearly expressed in almost all tissues with high rates of fatty acid uptake and lipid metabolism [7, 8] . Fatty acids shift to long-chain fatty acids that are transported by
FABPs to various tissues, where they are metabolized, stored, or utilized [8] . Fatty acids such as EPA can be metabolized into a large, diverse family of bioactive lipid mediators called eicosanoids, which may function as anti-inflammatory mediators [9] [10] [11] . 
Discussion
Reverse docking is a computing-based method that can be used to search for patterns of interaction involving molecular docking (drug/ligand) on a potential binding site 
Conclusion
This study proves that EPA has potential as an anti-inflammatory agent in OCD by interacting with fatty acid-binding protein 4 (FABP 4), which activates anti-inflammatory effects. EPA and hydrocortisone are able to interact with the FABP 4 on the same binding site. When the binding affinity of EPA has a higher bond than that of hydrocortisone, it has the potential to be an alternative anti-inflammatory medicine in OCD cases.
